Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis; Christopher Baum; Nissim Benvenisty; Gustavo Mostoslavsky; Hideyuki Okano; William L. Stanford; Matthew Porteus; Michel Sadelain

doi:10.1016/j.stem.2010.09.010

Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis^*, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

^*Corresponding author for this work

Department of Genetics

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English
Pages (from-to)	429-430
Number of pages	2
Journal	Cell Stem Cell
Volume	7
Issue number	4
DOIs	https://doi.org/10.1016/j.stem.2010.09.010
State	Published - 8 Oct 2010

Access to Document

10.1016/j.stem.2010.09.010

Cite this

@article{9c95f481110f4d6a9a1facf8087651a4,

title = "Benefits of utilizing gene-modified iPSCs for clinical applications",

author = "James Ellis and Christopher Baum and Nissim Benvenisty and Gustavo Mostoslavsky and Hideyuki Okano and Stanford, {William L.} and Matthew Porteus and Michel Sadelain",

year = "2010",

month = oct,

day = "8",

doi = "10.1016/j.stem.2010.09.010",

language = "אנגלית",

volume = "7",

pages = "429--430",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Benefits of utilizing gene-modified iPSCs for clinical applications

AU - Ellis, James

AU - Baum, Christopher

AU - Benvenisty, Nissim

AU - Mostoslavsky, Gustavo

AU - Okano, Hideyuki

AU - Stanford, William L.

AU - Porteus, Matthew

AU - Sadelain, Michel

PY - 2010/10/8

Y1 - 2010/10/8

UR - http://www.scopus.com/inward/record.url?scp=77957359122&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.09.010

DO - 10.1016/j.stem.2010.09.010

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 20887948

AN - SCOPUS:77957359122

SN - 1934-5909

VL - 7

SP - 429

EP - 430

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 4

ER -

Benefits of utilizing gene-modified iPSCs for clinical applications

Access to Document

Other files and links

Cite this